WeChat

Mobile website

Archive > Volume 20 Issue 1 > 2013,20(1):105-109. DOI:10.3872/j.issn.1007-385X.2013.1.018 Prev Next

Review

Crizotinib: Potential standard treatment for EML4-ALK positive patients with advanced non-small cell lung cancer

  • Article
  • Figures
  • Metrics
  • Preview PDF
  • Reference
  • Related
  • Cited by
  • Materials
    Abstract:


    Keywords:


    Project Supported:
    Project supported by the National Natural Science Foundation of China (No. 30901788,No. 81272619), and the Natural Science Foundation of Shandong Province (No. ZR2010HQ038, No. ZR2010HM059)

    Clc Number:
您是第位访问者
Chinese Journal Of Cancer Biotheray ® 2025 All Rights Reserved
Supported by:Beijing E-Tiller Technology Development Co., Ltd.